{"docid":"VWS-WOO-Spc-196394","collapsed":true,"count":1,"unchecked":0,"snapshots_total":1,"versions":[{"archive_id":"14425","bestandsnaam":"VWS-WOO-Spc-196394-Cover_Letter_to_the_EC_Term_Sheet_2_-_signed.pdf","created_date":"2025-02-18 12:18:00","last_seen":"2025-02-18 12:18:00","from_file":"Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","snippet":"CONFIDENTIAL SANOFNy)\nNon Binding Term Sheet dated June 29\", 2020\nTo:European Commission Negotiation Team\nDue tothe urgency and degree ofthe COVID-19 pandemic, Sanofi and GSK are fully committed to\nde","digest":"194486dc2ba2","dupes":1,"date_to":"2025-02-18 12:18:00","date_from":"2025-02-18 12:18:00","unchecked":false}],"raw":[{"archive_id":"14425","bestandsnaam":"VWS-WOO-Spc-196394-Cover_Letter_to_the_EC_Term_Sheet_2_-_signed.pdf","created_date":"2025-02-18 12:18:00","last_seen":"2025-02-18 12:18:00","from_file":"Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","snippet":"CONFIDENTIAL SANOFNy)\nNon Binding Term Sheet dated June 29\", 2020\nTo:European Commission Negotiation Team\nDue tothe urgency and degree ofthe COVID-19 pandemic, Sanofi and GSK are fully committed to\nde","digest":"194486dc2ba2"}],"filename":"Cover Letter to the EC Term Sheet 2 - signed.pdf","truncated":false,"elapsed_ms":12}